New Interventions for Menopausal Symptoms (U01)

The summary for the New Interventions for Menopausal Symptoms (U01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	New Interventions for Menopausal Symptoms (U01)
	CFDA Number:	93.21393.865
	CFDA Description:	Research and Training in Complementary and Alternative Medicine 93.865 Child Health and Human Development Extramural Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Income Security and Social Services Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-AG-08-004
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Jul 18, 2007
	Creation Date:	Jul 18, 2007
	Original Closing Date for Applications:	Nov 24, 2007
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Dec 24, 2007
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	$4,350,000
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	93.866 -- Aging Research

Applicants Eligible for this Grant: Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education State governments Others (see text field entitled "Additional Information on Eligibility" for clarification) City or township governments County governments For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Special district governments
Additional Information on Eligibility: Foreign institutions are not eligible to apply. Eligible agencies of the Federal Government can apply.
Grant Description: Women going through the menopause transition may experience a variety of symptoms, ranging from vasomotor symptoms (hot flashes and night sweats) to sleep disturbance, mood disorders, loss of sexual desire, and vaginal dryness. As many as two-thirds of all women report vasomotor symptoms, and over 85% report at least one menopausal symptom as they transition through menopause. For the 25% of women whose symptoms are severe, the resulting discomfort greatly diminishes their quality of life. For many decades, menopausal hormone therapy (MHT) using estrogen (or, in a woman with a uterus, a combination of estrogen and a progestin) has been the therapy of choice for relieving menopause-related symptoms. But recently, several large clinical trials, and in particular, the Women s Health Initiative, have found an increased risk of serious health problems, such as blood clots, stroke, heart disease, breast cancer and cognitive impairment, in women using estrogen-progestin regimens. Not surprisingly, women are reluctant to use MHT for menopausal symptoms and in search of alternative strategies to improve their quality of life.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-08-004.html http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-08-004.html
Grant Announcement Contact: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster